| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
VYNE Therapeutics (NASDAQ:VYNE) reported its Q4 earnings results on Thursday, February 29, 2024 at 08:00 AM.
Here's what investors need to know about the announcement.
VYNE Therapeutics beat estimated earnings by 64.0%, reporting an EPS of $-0.18 versus an estimate of $-0.5.
Revenue was up $70 thousand from the same period last year.
Last quarter the company beat on EPS by $0.22 which was followed by a 3.0% increase in the share price the next day.
To track all earnings releases for VYNE Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: VYNE
